about
Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virusDendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle?Factors Affecting Serum Concentrations of Hepatitis C Virus (HCV) RNA in HCV Genotype 1-Infected Patients with Chronic HepatitisInteraction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcomeHost Genetic Factors and Antiviral Immune Responses to Hepatitis C VirusFactors associated with spontaneous clearance of hepatitis C virus among illicit drug usersRegulatory Polymorphisms in the Interleukinâ18 Promoter Are Associated with Hepatitis C Virus ClearanceEthnic and geographical differences in HLA associations with the outcome of hepatitis C virus infectionEffect of Killer Immunoglobulin-Like Receptors in the Response to Combined Treatment in Patients with Chronic Hepatitis C Virus InfectionMutational escape of CD8+ T cell epitopes: implications for prevention and therapy of persistent hepatitis virus infectionsA comparative review of HLA associations with hepatitis B and C viral infections across global populationsStatistical linkage analysis of substitutions in patient-derived sequences of genotype 1a hepatitis C virus nonstructural protein 3 exposes targets for immunogen designRole of human leukocyte antigen class I alleles in progressive multifocal leukoencephalopathy.Effect of HLA on hepatitis C virus clearance and persistence in anti-HCV-positive end-stage renal disease patientsMolecular mechanisms of liver fibrosis in HIV/HCV coinfectionHuman leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllers.KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infectionSpecific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremiaHepatitis C virus infection in the human immunodeficiency virus infected patient.The efficiency of the human CD8+ T cell response: how should we quantify it, what determines it, and does it matter?Epidemiological and genetic correlates of severe acute respiratory syndrome coronavirus infection in the hospital with the highest nosocomial infection rate in Taiwan in 2003.Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes.T cell receptor recognition of self and foreign antigens in the induction of autoimmunity.Hemophilic siblings with chronic hepatitis C: Familial aggregation of spontaneous and treatment-related viral clearanceEffects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infectionThe relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected womenHost genetic determinants of spontaneous hepatitis C clearance.Coinfection with HIV-1 and HCV--a one-two punch.Role of host genetic factors in the outcome of hepatitis C virus infection.Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infectionHLA-B alleles B*15:01 and B*15:02: opposite association with hepatitis C virus infection in Chinese voluntary blood donors.Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitopeCompensatory mutations restore the replication defects caused by cytotoxic T lymphocyte escape mutations in hepatitis C virus polymerase.Demographics, socio-behavioral factors, and drug use patterns: what matters in spontaneous HCV clearance?Escape from a dominant HLA-B*15-restricted CD8+ T cell response against hepatitis C virus requires compensatory mutations outside the epitope.Host genetic determinants in hepatitis C virus infection.Update on hepatitis C virus-specific immunityLytic and latent antigens of the human gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus induce T-cell responses with similar functional properties and memory phenotypesNatural evolution of hepatitis C virus infection in hemodialysis Tunisian patients and CTLA-4 SNP's.Host and viral factors contributing to CD8+ T cell failure in hepatitis C virus infection
P2860
Q24596652-B9C59680-1D2F-4972-8351-CEDFD18FFCCEQ27010312-3DC8DDCF-8BC7-4F0E-B91F-BC9F68D50658Q27480999-3C3F32AF-9328-4EE5-BA14-7A656D476816Q27486089-99414407-BA5D-4FCF-BB25-524D51367424Q27487445-D47B31B1-6800-470F-8E6D-ACE0D5C8BEF1Q27488233-2F5092CF-3D4A-4085-80BE-7F06201D1D1BQ27488349-E0351F2B-90D0-4EC1-9C45-B6D8E4B28A7AQ27488372-2B4DFEA4-C466-44F5-A9DE-57B383589130Q27490541-46ACB7CA-8AE6-45E5-9D20-C25390C164DEQ28086907-50E4F755-3E90-4BA0-A884-65933E580EF0Q28299722-EA22B56C-99E0-492B-B67B-E2F083E0B97AQ30361685-318B0EEF-F83F-4D8D-A180-796061863B1EQ33789032-2C4E5818-C6D9-4146-8A02-825C5136483BQ33796039-FC7A1D2C-552A-4E60-947A-DBF4ACD91EFBQ33907429-B37FE51F-CEAE-43C5-A338-3CF3F0F03FE3Q34015054-AA4C0B65-7969-46E2-B3CB-951E35FD8826Q34055276-8424C88F-68B6-45CE-BBA6-8A80566AB526Q34158520-DFEA5AC1-9BB4-485F-ADEE-8FF9A5515F93Q34168504-BD7CBE80-996A-4C83-AAF4-E4881A078BBEQ34181287-FD27812F-E86B-43CC-83A5-4E11532B944CQ34430859-C7942366-165A-4C06-8D2F-391E3C0E10FDQ34493947-7DCBB6E0-0FE4-4295-ACB2-E90C2516D294Q34777861-157DD136-3529-4DED-B507-E0812902B42BQ34914406-ACF61F95-5008-4BF6-893C-9D3FF75697B4Q34994754-88B583A2-DBD9-4C41-9531-FD2017747ECEQ35000910-A0F30F6C-28FF-477A-9BBE-C36F08F4B9D1Q35011376-DC542BDC-2408-4DE2-A499-947E27C3ECB0Q35137038-98D4E912-F1BF-4C11-BEF2-347E5FE38FAFQ35259735-B3840635-A0B7-4A5B-A6D2-ABFF42966C86Q35350883-0B699381-F8B3-4E62-9F63-A9422A0CD6B5Q35374519-518F145D-42E8-4C02-8BC8-ECAB405AE456Q35404598-C8C676C2-9734-44C9-B183-6FACDC4EC574Q35531173-19749CF2-ACA3-42EF-A970-C32967EB4D28Q35654548-9724B806-31AA-470C-AEBE-AAE5CBCAFFCBQ35665865-6EA53B4B-C5AB-4EF0-B361-50244C076BABQ35753723-7BF8258F-8006-4F07-8CD9-43B38A76807FQ35839496-9EA67502-3D6C-4896-B9CC-533BCB173A18Q35857401-C4380791-D723-4D96-8647-B1538825C757Q36067577-D86C6311-BF2A-4C9C-A692-2C6BF932552AQ36179703-F1874AAE-01EC-42CB-BF83-DD6CBF8C1B65
P2860
description
2002 nĂŽ lĹŤn-bĂťn
@nan
2002 ŐŠŐ¸ÖŐĄŐŻŐĄŐśŐŤ ŐŐĄŐľŐŤŐ˝ŐŤŐś Ő°ÖŐĄŐżŐĄÖŐĄŐŻŐ¸ÖŐĄŐŽ ŐŁŐŤŐżŐĄŐŻŐĄŐś ŐľÖ
Ő¤Ő¸ÖŐĄŐŽ
@hyw
2002 ŐŠŐžŐĄŐŻŐĄŐśŐŤ Ő´ŐĄŐľŐŤŐ˝ŐŤŐś Ő°ÖŐĄŐżŐĄÖŐĄŐŻŐžŐĄŐŽ ŐŁŐŤŐżŐĄŐŻŐĄŐś Ő°Ő¸Ő¤ŐžŐĄŐŽ
@hy
2002ĺš´ăŽčŤć
@ja
2002ĺš´ĺŚćŻćçŤ
@wuu
2002ĺš´ĺŚćŻćçŤ
@zh-cn
2002ĺš´ĺŚćŻćçŤ
@zh-hans
2002ĺš´ĺŚćŻćçŤ
@zh-my
2002ĺš´ĺŚćŻćçŤ
@zh-sg
2002ĺš´ĺ¸čĄćçŤ
@yue
name
HLA-Cw*04 and Hepatitis C Virus Persistence
@nl
HLA-Cw*04 and hepatitis C virus persistence.
@ast
HLA-Cw*04 and hepatitis C virus persistence.
@en
type
label
HLA-Cw*04 and Hepatitis C Virus Persistence
@nl
HLA-Cw*04 and hepatitis C virus persistence.
@ast
HLA-Cw*04 and hepatitis C virus persistence.
@en
prefLabel
HLA-Cw*04 and Hepatitis C Virus Persistence
@nl
HLA-Cw*04 and hepatitis C virus persistence.
@ast
HLA-Cw*04 and hepatitis C virus persistence.
@en
P2093
P2860
P1433
P1476
HLA-Cw*04 and hepatitis C virus persistence.
@en
P2093
Chloe L Thio
David L Thomas
Jacquie Astemborski
James J Goedert
Kenrad E Nelson
Margaret W Hilgartner
Peter Karacki
Stephen J O'Brien
Xiaojiang Gao
P2860
P304
P356
10.1128/JVI.76.10.4792-4797.2002
P577
2002-05-01T00:00:00Z